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Abstract
Background: Sequence and structural elements in the 3’-untranslated region (UTR) of Japanese encephalitis virus
(JEV) are known to regulate translation and replication. We previously reported an abundant accumulation of small
subgenomic flaviviral RNA (sfRNA) which is collinear with the highly conserved regions of the 3’-UTR in JEV-
infected cells. However, function of the sfRNA in JEV life cycle remains unknown.
Results: Northern blot and real-time RT-PCR analyses indicated that the sfRNA becomes apparent at the time point
at which minus-strand RNA (antigenome) reaches a plateau suggesting a role for sfRNA in the regulation of
antigenome synthesis. Transfection of minus-sense sfRNA into JEV-infected cells, in order to counter the effects of
plus-sense sfRNA, resulted in higher levels of antigenome suggesting that the presence of the sfRNA inhibits
antigenome synthesis. Trans-acting effect of sfRNA on JEV translation was studied using a reporter mRNA
containing the luciferase gene fused to partial coding regions of JEV and flanked by the respective JEV UTRs. In
vivo and in vitro translation revealed that sfRNA inhibited JEV translation.
Conclusions: Our results indicate that sfRNA modulates viral translation and replication in trans.
Background
Japanese encephalitis virus (JEV), a member of the Fla-
viviridae family, is a major zoonotic agent. Pigs and
birds are the principal viremic hosts and mosquitoes are
responsible for the transmission between these verte-
brates to human [1]. In humans, JEV causes acute
meningomyeloencephalitis with high mortality rate [2].
The JEV genome is a single-stranded positive sense
RNA of about 10,976-nts that encodes a single large
open reading frame (ORF) flanked by a 95-nucleotide
(nt) long 5’ untranslated region (UTR) and a 585-nt
long 3’ UTR with no poly A tail. Cap-dependent transla-
tion of the JEV ORF results in a polyprotein which is
co- and post-translationally processed by viral as wells
as host proteases to yield three structural proteins (C,
prM, and E), and seven nonstructural proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B and NS5)[3].
As with all positive-sense RNA viruses, JEV RNA
replication begins with the synthesis of negative-strand
antigenome, which serves as a template for the synthesis
of progeny positive-strand genomic RNA. The asym-
metric RNA replication leading to 10- to 100-fold excess
of positive strands over negative strands which was
observed in Kunjin virus and dengue virus (DENV), and
in JEV infected cells [4-7]. In addition to genome and
antigenome, flaviviruses produce a small subgenomic
RNA (named sfRNA) representing highly conserved
regions of the 3’-UTR [8-11]. The sfRNA is more abun-
dant in JEV-infected mosquito cells than mammalian
cells and the molar ratio of sfRNA to genomic RNA can
range from 0.25 to 5.14 [8]. The abundant accumulation
of this RNA suggests that it may play an important role
in viral life cycle. Using West Nile virus (WNV) as a
model, Pijlman et al. demonstrated that the sfRNA is a
product of incomplete degradation of viral genome by
cellular ribonuclease XRN1 and is essential for virus-
induced pathogenicity [11]. It was reported that a pseu-
doknot structure at the 3’-UTR is responsible for stalling
XRN1 from degrading the RNA further, which results in
sfRNA [9,10]. * Correspondence: rchang@mail.ndhu.edu.tw
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various important functions such as translation, replica-
tion, and encapsidation [12-17]. There are several func-
tional motifs in the 3’-UTR including the conserved
sequences (CS motifs), cyclization motifs, pseudoknot
structure, and the 3’-stemloop (3’-SL) motif. Two pairs
of cyclization motifs were reported. Hahn et al. first
reported that the 5’ and 3’ conserved sequences are
complementary to each other and potentially form a
cyclization structure [18]. The second pair of cyclization
motif is the upstream of AUG codon (5’UAR), which is
complementary to the sequences located in the 3’-UTR
(3’UAR). The UAR cyclization motifs have been shown
to be required for replication in DENV and WNV
[19-23]. In addition, Friebe and Harris identified another
element located downstream of the AUG (designated
5’DAR) also involved in DENV replication and possibly
genome cyclization [24]. Although these conserved
sequences were found in JEV, the functions of these
motifs have not been characterized in detail. Yun et al.
analyzed the 3’- U T Ro fJ E Va n dd e f i n e di ti n t os i x
domains [25]. By constructing serial deletion mutants,
they demonstrated that the two 3’-proximal domains are
sufficient for RNA replication, while the other four
domains are dispensable but required for maximal repli-
cation efficiency suggesting the cis-acting sequences
required for JEV replication might be slightly different
from those other flaviviruses. In addition to RNA-RNA
interactions, numerous studies have been shown that 3’-
UTR interacts with both viral and cellular proteins, and
is required for RNA synthesis and translation [15,26-36].
In JEV, viral NS3 and NS5 proteins as well as cellular
Mov 34 and La proteins have been shown to bind to the
3’-SL and play roles in viral replication [37-39]. Pre-
viously we showed that the cellular protein GAPDH
binds more efficiently to the 3’ end of minus-strand
RNA than to the 3’-SL of plus-strand RNA, suggesting a
role for promoting asymmetric RNA replication [40].
The presence of such essential motifs in sfRNA and its
abundance in infected cells present a compelling indica-
tion of a possible function that prompted us to elucidate
its role in the viral life cycle at the cellular level. We
f o u n dt h a th i g hl e v e l so fs f R N Aa c c u m u l a t e si nt h e
cytoplasm during the late stages of viral life cycle sug-
gesting that sfRNA may inhibit either viral translation
or minus-strand synthesis or both. To test this, plus- or
minus-strand forms of the sfRNA were separately trans-
fected in virus-infected cells and the effects on genome
and antigenome accumulation were measured. The
effect of sfRNA on JEV translation was determined by
co-transfecting plus or minus sense of sfRNA with a
luciferase reporter RNA for in vivo translation studies in
cultured cells and a rabbit reticulocyte lysate assay sys-
tem was used for in vitro translation studies. Our results
indicated that the sfRNA inhibits antigenome synthesis
and also down regulates viral translation in trans.
Results
sfRNA localizes to the cytoplasm along with a major
proportion of genomic RNA while a small proportion of
genomic RNA is localized in the nucleus
Replication of flavivirus RNA takes place mainly in the
cytoplasm, however, the major replicase proteins NS3
and NS5 were also found to localize within the nucleus
[41]. To determine subcellular distribution of the
sfRNA, which is important toward to understanding its
function, total RNA from the nuclear and cytoplasmic
fractions from both uninfected and infected BHK-21
cells were subjected to Northern blot analysis using
3JEV10950(-) oligonucleotide probe that detects genome
and the sfRNA (Figure 1A). The results showed that the
sfRNA and the genomic RNA could be detected in the
total RNA extract and the cytoplasmic fraction (Figure
1A, lanes 4 and 5). In the nuclear fraction, only a few
genomic RNA was detected, whereas the sfRNA was not
detected at all (Figure 1A, lane 6). These signals were
not detected in any of the fractions of the uninfected
cells (Figure 1A, lanes 1 to 3). Mitochondrial 12S rRNA
was used as a cytoplasm specific subcellular marker to
exclude the possibility of the JEV genomic RNA
detected in the nuclear extract coming from cytoplasmic
contamination during fractionation. As shown in Figure
1B, the 12S rRNA was detected in the total RNA extract
and cytoplasmic fraction (lanes 1, 2, 4, 5) but not in the
nuclear fraction (lanes 3, 6), indicating that the subcellu-
lar fractionation of nucleus versus cytoplasm was accu-
rate and efficient.
Time course study of viral genome and antigenome
synthesis in JEV-infected cells
To determine the appearance of the sfRNA with the
kinetics of genome and antigenome, cells were infected
with JEV at an multiplicity of infection (MOI) of 0.01,
the RNA was extracted at 4 h intervals during a 48-h
postinfection period and analyzed by Northern blot. The
probe used was 3JEV10950(-) oligonucleotide which
detects RNA containing the very 3’-terminal 27 nts of
the JEV genome. The results showed that genomic RNA
w a sd e t e c t e da t2 2ha n ds f R N Aa t2 8hp o s t i n f e c t i o n ,
and their abundance continued to increase throughout
the experimental period (48 h; Figure 2A). To more pre-
cisely determine the kinetics of genome and antigenome
accumulation in JEV-infected cells in context of sfRNA,
cytoplasmic RNAs extracted at the indicated time points
were subjected to one-step real-time RT-PCR. Sequence
specific primer designed for the genome or antigenome
w a su s e dd u r i n gR Ts t e p( F i g u r e2 B ) .Al i n e a rs t a n d a r d
curve obtained from known input RNA copies to the
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was determined (data not shown). The amount of intra-
cellular genome or antigenome per cell was calculated
by dividing the copy number of genomic or antigenomic
RNA by the number of cells counted at each time point.
A ss h o w ni nF i g u r e2 Ca n d2 D ,t h eg e n o m i cR N Aw a s
4.64 × 10
3 copies per cell at 24 h postinfection, and its
abundance continued to increase throughout the 48-h
infection period, except for a slight diminution at 44 h
postinfection. The RNA levels reached to 2.91 × 10
5
copies per cell at 48 h postinfection. The accumulation
of the antigenome followed the same trend as the geno-
mic RNA throughout the experimental period but the
amount was less by one to two orders of magnitude
than that of genomic RNA. From 24 to 48 h postinfec-
tion there was a 63-fold increase in genome accumula-
tion whereas only a 15-fold increase for the antigenome
indicating that the increasing rate of genomic RNA
accumulation is nearly four times faster than that of the
antigenomic RNAs (Figure 2D). Interestingly, as shown
in Northern analysis the sfRNA becomes apparent at
the time point when antigenome reaches a plateau sug-
gesting a role for sfRNA in the regulation of minus
strand synthesis.
The presence of the sfRNA inhibits antigenome synthesis
To elucidate the possible function of the sfRNA during
viral replication, plus- and minus-strand forms of the
sfRNA was separately transfected in virus-infected cells
and the effects on genomic and antigenomic
accumulation were measured. The intention for the
transfection of minus-strand sfRNA into JEV-infected
cells was to counter the effects of the naturally occur-
ring plus-strand sfRNA and observe the outcome. BHK-
21 cells were infected with JEV at an MOI of 0.01 and
in vitro transcribed plus- or minus-strand forms of the
sfRNA were transfected separately at 28 h postinfection,
at which time point the sfRNA was detected by North-
ern blot in mammalian cells (Figure 2A, lane 4). Cyto-
plasmic RNAs were extracted and examined with
Northern blotting using in vitro transcribed DIG-labeled
riboprobes to detect plus- and minus-strands, respec-
tively. The results showed that transfection of the (+)
sfRNA did not affect genomic or antigenomic RNA
accumulation compared to mock transfection (Figure
3A and 3B, lanes 3, 6, 9), while transfecting of the (-)
sfRNA increased amount of antigenome synthesis at 48
h postinfection (Figure 3B, lane 10). Interestingly, an
RNA band slightly higher than the antigenome was
observed when transfecting of (-)sfRNA (Figure 3B,
lanes 4, 7, 10). This higher molecular weight molecule
was not detected when transfecting with (+)sfRNA or
mock transfected cells. The input (-)sfRNA was tran-
scribed from SP6 promoter of the Nco I-linearized
pGEMT/JEV10450-10976 resulting in extra 75 nts at the
5’-end and 15 nts at the 3’ end derived from vector
sequences. These extra sequences could have primed
cellular sequences during the amplification step result-
ing in an unexpected band. To generate a (-)sfRNA with
precise sequences complementary to the authentic
mtRNA
sfRNA
genome
A
12 3 456 1 2 3 4 56
B
Uninf.           
T CNT CN
48 hpi Uninf.           
T CN T CN
48 hpi
Figure 1 Northern analysis of cytoplasmic and nuclear RNA fraction. RNA was extracted from uninfected BHK-21 cells (uninf.) and from cells
infected with JEV at MOI of 0.1 at 48 h postinfection. Northern analysis was performed using DIG-labeled oligonucleotides complementary to nts
10,950-10,976 in the 3’-UTR (A) or to mitochondria RNA (mtRNA) (B). T, total RNA extract; C, cytoplasmic fraction, and N, nuclear faction.
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Figure 2 Kinetics of genomic and antigenomic RNA synthesis in JEV-infected BHK-21 cells. A. BHK-21 cells were infected with JEV at an
MOI of 0.01, and cytoplasmic RNAs were extracted at the indicated time points postinfection and were subjected to Northern analysis as
described in Fig.1. Oligonucleotide probe detecting 18S rRNA is shown at the bottom. B. Diagram of primer positions and the vector used for
generating RNA transcripts as standards for real-time RT-PCR assay. C. The RNAs were subjected to real-time RT-PCR assay. Amounts of genome
and antigenome per cell were plotted and calculated (C and D). Vertical arrow in panel C indicates the time when sfRNA becomes apparent.
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Figure 3 Effect of (+)sfRNA and (-)sfRNA on JEV RNA synthesis, when transfected into JEV-infected BHK-21 cells.Aa n dB .C e l l sw e r e
either left uninfected (uninf., lane 1), or infected (lanes 2-10) with JEV at an MOI of 0.01. Plus-sense (+) (lanes 3, 6 and 9) and minus-sense (-)
(lanes 4, 7 and 10) of sfRNAs were transfected at 28 hpi, or mock transfected (lanes 2, 5 and 8). Cytoplasmic RNA was extracted at the indicated
hours post-infection (hpi). RNA was probed with a DIG-labeled minus-sense sfRNA to detect plus strands (A) or with plus-sense sfRNA to detect
minus-strands (B). Oligonucleotide probe detecting 18S rRNA is shown at the bottom. C and D. Cells were either left uninfected (uninf., lane 1),
or infected (lanes 2-7) with JEV at an MOI of 0.01. Minus-sense of sfRNAs (lanes 5-7) were transfected at 28 h postinfection (hpi), or mock
transfected (lanes 2-4). Cytoplasmic RNA was extracted at the indicated time point. Dig-labeled riboprobes were used as indicated at the top.
Oligonucleotide probe detecting 18S rRNA is shown at the bottom. Effect of transfecting (-)sfRNA into the JEV-infected BHK-21 cells on genome
(E) or antigenome (F) was plotted. Error bars indicate the standard deviations of results from three independent experiments.
Fan et al. Virology Journal 2011, 8:492
http://www.virologyj.com/content/8/1/492
Page 5 of 11sfRNA, we then constructed pUC18/JEV(-)10976-10454
and used for generating (-)sfRNA without extra
sequences at the termini. Transfecting of the (-)sfRNA
did not have significant influence on the accumulation
of genome (Figure 3C), while the amount of antigenome
increased compared to mock transfection (Figure 3D).
These experiments were repeated at least three times
and the amount of RNA on each lane was quantitated
by densitometry, normalized to 18S rRNA, and com-
pared to mock transfection (Figure 3E and 3F). The
results showed that transfection of (-)sfRNA did counter
the effects of sfRNA resulting in higher levels of antige-
nome (Figure 3D and 3F). These results suggest that the
presence of the sfRNA plays a role in the inhibition of
antigenome synthesis.
The sfRNA inhibits translation
It has been shown that the 3’-UTR possesses many
highly ordered secondary structures involved in viral
translation most of which are also present in sfRNA. To
test whether the presence of sfRNA affects viral transla-
tion, a JEV minicon containing Renilla luciferase repor-
ter gene constructed with authentic JEV 5’ and 3’ UTRs
and part of the coding sequences (Figure 4A; described
in Materials and Methods) was used. In vitro transcribed
minicon RNA was cotransfected with either (+)sfRNA,
(-)sfRNA, or control RNA (cRNA) and effects on repor-
ter translation were measured at 8 h posttransfection.
Interestingly, transfecting either (+)sfRNA or (-)sfRNA
but not control RNA inhibited luciferase translation dri-
ven by JEV 5’ UTR (Figure 4B). Consistent with in vivo
translation assay, in vitro translation of luciferase was
inhibited by the addition of (+)sfRNA as well as (-)
sfRNA in rabbit reticulocyte lysate (Figure 4C). In order
to confirm if the (-)sfRNA could counter the effects of
(+)sfRNA, both sense and antisense sfRNA were added
simultaneously into the in vitro translation mix to mea-
sure their effect on minicon translation. As shown in
Figure 4D, the inhibitory effect of (+)sfRNA on transla-
tion was rescued by the addition of (-)sfRNA. When
equimolar amounts of plus-sense and minus-sense
sfRNA were added to the reaction, translation was
restored to control (minicon only) levels.
Discussion
The discovery of sfRNA in flaviviruses has generated
considerable interest in its generation, localization, and
its possible function in flavivirus infected cells. In this
study, we have shown that JEV sfRNA is localized in
cytoplasm along with the genomic RNA (Figure 1A).
Although the biogenesis of JEV sfRNA has not yet been
studied, it has been reported that in WNV and YFV,
sfRNA is a product of incomplete degradation of viral
genome by cellular ribonuclease XRN1 and is co-
localized to the P-body in the cytoplasm [11]. Consistent
with their report we found that JEV sfRNA is also loca-
lized to the cytoplasm along with the genomic RNA. On
t h eo t h e rh a n d ,w ea l s of o u n dt h a taf e wg e n o m i cR N A
is also localized to the nucleus consistent with reports
on the presence of flaviviral proteins and flaviviral RNA
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Figure 4 Effect of sfRNA on viral translation in cultured cells
and in vitro. A. A diagram of the JEV minicon RNA is shown. B. JEV
minicon RNAs were transcribed in vitro without or with capped
analog and then transfected alone (-) or cotransfected with (+)
sfRNA, (-)sfRNA, or control RNA (cRNA). The Renilla luciferase activity
of cell lysates was determined at 8 h posttransfection. C. Renilla
luciferase assays of JEV minicon RNA translated in rabbit reticulocyte
lysate in the presence of (+)sfRNA, (-)sfRNA or control RNA. D. The
effect of different amounts of (+)sfRNA or (-)sfRNA on in vitro
translation of minicon RNA in rabbit reticulocyte lysate. The Renilla
luciferase activity of cell lysate with five different treatments is
shown. *** represents P < 0.005 in comparison with capped JEV
minicon only.
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Page 6 of 11replication in the nuclear fraction [41-43]. The presence
of abundant sfRNA in the cytoplasm of infected cells
hints at possible roles of the sfRNA in cytoplasmic
events during infection, namely viral RNA replication
and translation.
The RNA synthesis of plus-strand RNA viruses is
asymmetrical meaning that positive-sense genomic RNA
strands are generated in excess over minus sense antige-
nome and the ratio is about 10:1 to 100:1. Northern ana-
lysis from a previous study showed that the ratio of plus-
to-minus strands at 8 h postinfection was 3:1 which
rapidly increased thereafter to 11.7:1 by 18 h postinfec-
tion in porcine kidney cells infected with JEV at an MOI
of 10 [7]. In this study, we describe the kinetics on the
synthesis of JEV genome and antigenome in BHK-21
cells at an MOI of 0.01 using strand specific oligonucleo-
tides for real-time RT-PCR. Our results indicated that
the ratio of plus-to-minus strands during 24-48 h postin-
fection was in the range of 29:1 to 244:1 during inspec-
tion period (Figure 2D). Interestingly, we found that the
time point at which the antigenome accumulation
reaches a plateau coincides with the appearance of
sfRNA as shown in our results from Northern and real-
time RT-PCR analyses. It would be ideal to show the
time course of antigenome and sfRNA accumulation
together but since it was impossible to distinguish sfRNA
accumulation from genomic RNA accumulation in real-
time RT-PCR experiments, we employed Northern analy-
sis which clearly distinguishes the two (Figure 2A). The
time course of antigenome, on the other hand, real-time
RT-PCR is much more sensitive than Northern analysis
especially during the early time points (Figure 2C). Thus,
we compare the same amounts of RNA under the same
condition by these two different methods.
The artificial addition of (-)sfRNA (by transfection) at
28 h postinfection countered the effects of naturally
occurring sfRNA thereby increasing the accumulation of
antigenome (Figure 3D and 3F) indicating that sfRNA
could negatively interfere with antigenome synthesis. The
addition of (-)sfRNA may not only anneal to the naturally
occurring plus-sense sfRNA but also to the 3’-UTR of the
genomic RNA. However, the probability of the minus-
sense sfRNA to bind to the plus-sense sfRNA is more
than its binding to the genomic 3’-UTR because of (i) the
binding strength of same size shorter complementary
RNA should be greater than the binding of a short RNA
sequence to a large RNA polynucleotide akin to a highly
complementary primer dimer and a PCR template. This
was observed in our in vitro luciferase assays (Figure 4)
where the individual addition of either only (+)sfRNA or
(-)sfRNA reduced translation but the addition of both (+)
sfRNA (50 ng) and (-)sfRNA (10 ng) into the reaction
partially restored translation and the addition of more (-)
sfRNA (50 ng) restored translation to control levels
probably because the plus-sense and the minus-sense
sfRNA hybridized to form duplex RNA thereby prevent-
ing sfRNA from interfering with translation; (ii) cycliza-
tion of the genome could render the 3’-UTR inaccessible
to the minus-sense sfRNA. Curiously, when (-)sfRNA is
transfected, the amount of naturally occurring plus-sense
sfRNA does not decrease (Figure 3A and 3C) and is simi-
lar to that of mock, indicating that naturally occurring
plus-sense sfRNA is either not degraded or that the rate
of sfRNA generation (RNA turnover) is very high.
The presences of cis-acting sequences including promo-
ters, enhancers, and repressors that aid in the in regulation
of minus-strand synthesis have been reported in many plus-
strand RNA viruses [44-47] and these elements may conse-
quently contribute to asymmetrical RNA synthesis. Viral or
host proteins may also contribute to asymmetric replication
in trans [48-50]. Several RNA motifs within 5’ and 3’-UTR,
for instance, 5’-CS/CS1, 5’-UAR/3’-UAR, and 5’DAR/
3’DAR are involved in RNA-RNA interactions. These RNA-
RNA interactions have been demonstrated to be required
for viral replication. In DENV, a stemloop A (SLA) has
been identified at 5’ end of the genome which was shown
to be required for long-range RNA-RNA interaction and
the recruitment of virus RdRp which is then transferred to
t h ei n i t i a t i o ns i t ep r e s e n ti nt h e3 ’-UTR in order to promote
minus-strand RNA synthesis [51]. In addition, the balance
between circular and linear forms of the DENV genome is
crucial for viral replication [52]. Thus, the presumable
mechanism of the suppression of antigenome synthesis by
J E Vs f R N Am a yb ed u et ot h ei n t e r r u p t i o no fg e n o m ec y c l i -
zation by its complementarity to the 5’-end elements of JEV
genome (Figure 5A). Since the sfRNA is in high molar
excess it could also be assumed that free sfRNA (sfRNA not
bound to the 5’ of JEV genome) could further reduce anti-
genome synthesis through a second mechanism by compet-
ing for viral and host proteins that would otherwise bind to
the 3’ UTR and promote antigenome synthesis (Figure 5B).
We hypothesis that sfRNA through its trans-acting function
could be one of the factors contributing to the asymmetry
in JEV RNA replication.
It has also been reported that the RNA elements in
the flaviviral 3’-UTR influences viral translation effi-
ciency [13,15,33,35]. However, Alvarez et al. developed a
replicon system that can be used to discriminate
between translation and RNA replication. They demon-
strated that deletion of individual domains of the 3’-
UTR did not significantly affect viral translation but it
impaired or abolished RNA synthesis [12]. Our results
showed that JEV translation efficiency in cultured cells
w a sr e d u c e di nt h ep r e s e n c eo fs f R N A( F i g u r e4 ) .J E V
translation efficiency in vitro was also impaired in the
presence of sfRNA but was restored to control levels by
the addition of equal amounts antisense sfRNA into the
reaction. This clearly shows that sfRNA does impair JEV
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binding to 3’-UTR elements are essential to promote
viral translation. Transfection of (+)sfRNA sequesters
proteins binding to the 3’-UTR of genome and reduces
translation, while if (-)sfRNA is transfected it could bind
to the 3’-UTR of the genome and prevent the host pro-
teins from binding the 3’UTR (competes with host fac-
tors binding to the 3’UTR). In addition, transfection of
(-)sfRNA could also prevent the interaction of the 3’
and 5’ regions of the genome and that too could reduce
translation. Thus, transfecting of either (+) or (-)sfRNA
reduces translation. Furthermore, the sfRNA could
titrate the host factors and even the newly synthesized
viral proteins like RdRp thereby drastically reducing
minus-strand RNA synthesis that results in the afore-
mentioned asymmetry in RNA accumulation.
Conclusions
As seen in our results (Figures 2A, 3A and 3C), sfRNA
is present in great abundance in the late stages of the
viral replication cycle and that sfRNA interferes and
impairs both antigenome synthesis and JEV translation
(Figures 3 and 4). It could be thought that the JEV
genomic RNA produced during the late stages of the
viral replication cycle is bound for packaging and should
not be used as templates for antigenome synthesis or
for translation and the presence of sfRNA is suspected
to compete against the translation and antigenome
synthesis. From our data, we conclude that sfRNA could
be the switch (a trans-acting riboswitch) that shuts
down both antigenome synthesis and JEV translation
thereby promoting only genomic RNA synthesis that
needs to be packaged and released for the next infec-
tious cycle.
Materials and methods
Cells and viruses
Baby hamster kidney (BHK-21) cells were grown in
RPMI 1640 medium supplemented with 2% fetal bovine
serum (FBS) (Gibco-BRL) at 37°C. JEV strain RP9, a var-
iant of NT109 isolated originally from Culex tritaenior-
hynchus was used in this study [53].
Construction of plasmids
pGEMT/JEV3642-3821 plasmid (Figure 2B) used for
making RNA standard in real-time RT-PCR was
Genome cyclization aids in 
antigenome synthesis. 
Genome cyclization disrupted and 
antigenome synthesis reduced. 
sfRNA 
Proteins binding to 3’-UTR elements 
promotes translation/replication. 
Proteins sequestered by sfRNA and 
reduced translation/replication. 
NS3  La 
NS3  La 
NS3  La 
NS3  La 
3’ 
3’ 
3’ 
3’ 
A 
B 
Mov34 
NS5 
Mov34  NS5 
Mov34  NS5 
Mov34  NS5 
Figure 5 Model depicting the role of sfRNA in flaviviral RNA replication and translation. A. The diagrammatic representation of flaviviral
cyclization, through the cyclization elements, which promote antigenome synthesis. The sfRNA disrupts genome cyclization by interacting with
the 5’ cyclization elements and thereby reduces antigenome synthesis. B. Flaviviral genome contains protein-binding elements in the 3’-UTR. Viral
and host proteins bind to their respective RNA elements in the 3’-UTR and promote translation and replication. The presence of sfRNA
sequesters most of the proteins reducing its availability for flaviviral translation and replication.
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from JEV cDNA with the JEV3642(+) (nt 3642-3662)
and JEV3821(-) (nt 3802-3821) primers into pGEMT-
easy vector (Promega). To generate pGEMT/JEV10450-
10976 construct, we followed the same method as for
pGEMT/JEV3642-3821 plasmid, except that JEV10450(-)
(nt 10450-10476) and JEV10950(+) (nt 10950-10976)
primers were used for PCR. PCR products were ampli-
fied from sfRNA with primers containing T7 promoter
at 5’ end and a unique restriction site at the 3’ end, then
cloned into pUC18 plasmid to generate pUC18/JEV(+)
10450-10976, and pUC18/JEV(-)10976-10454 for making
(+)sfRNA and (-)sfRNA respectively. Sequences of each
construct were confirmed by sequencing.
RNA preparation and Northern blot analysis
RNA extraction and Northern analyses were done as
described previously [8]. Briefly, total RNA was
extracted with Trizol (Invitrogen) or REzol™ C&T
reagent (Protech). Cytoplasm/Nucleus fractionation was
done using Cytoplasmic & Nuclear RNA Purification kit
(Norgen) according to manufacturer’si n s t r u c t i o n .
Approximate 2.5 μgo r7 - 1 0μg of cytoplasmic RNA
were used per lane in formaldehyde-agarose gel electro-
phoresis for the detection of plus- or minus-strand,
respectively. To label oligonucleotide probe, approxi-
mately 100-pmol of oligonucleotide was 3’ tailed with
Digoxigenin (DIG)-ddUTP using a DIG Oligonucleotide
3’-End Labeling Kit (Roche Molecular Biochemicals).
For labeling sfRNA probe, 1 μg of linearized DNA was
used for in vitro transcription with DIG RNA labeling
mix (Roche Molecular Biochemicals). Hybridization was
done at 54°C for oligonucleotide probes and 68°C for
riboprobes. DIG luminescent detection of the viral spe-
cific bands was done according to the manufacturer’s
instructions (Roche Molecular Biochemicals).
Synthetic oligonucleotides and accession number
JEV genome nucleotide positions correspond to those
for JEV RP9, GenBank accession number AF014161.
3JEV10950(-) oligonucleotide (5’-AGATCCTGTGTT
CTTCCTCACCACCAG-3’) detects RNA containing the
very 3’-terminal 27 nts of the JEV genome. 18S rRNA(-)
oligonucleotide (5’-GCACTTACTGGGAATTCCTCG-
3’) location corresponds to mouse 18S rRNA, GenBank
accession number X00686. Mitochondria 12S rRNA(-)
oligonucleotide (5’-AAGGCCAGGACCAACCT-3’)w a s
synthesized according to GenBank accession number
NC_005089.
Real-time RT-PCR
The method used for real-time RT-PCR assay was as
described previously [54]. The in vitro transcripts of posi-
tive-sense RNA were generated from T7 transcription
(Promega) of the Sal I-linearized pGEMT/JEV3642-3821
and the minus-sense transcripts were transcribed from
SP6 promoter of the Nco I-linearized pGEMT/JEV3642-
3821 (as diagramed in Figure 2B). The amount of purified
RNA was measured by spectrophotometry and the copy
number was calculated based on the concentration mea-
sured and its molecular weight. The known amounts of
RNAs were serially diluted 10-fold (1.78 × 10
11 to 1.78 ×
10
5 copies) and subjected to real-time RT-PCR using the
one-step RT-PCR master mix reagent kit following the
manufacturer’s instructions (Applied Biosystems). Oligo-
nucleotides JEV3642(+) and JEV3821(-) were used as pri-
mers for binding to minus and plus-strand RNA,
respectively, during RT step carried out at 48°C for 30
min. The PCR amplification conditions were 95°C for 10
min, followed by 40 cycles of 95°C for 15 sec and 60°C
for 1 min with primers JEV3650(+), JEV3726(-) and Taq-
Man probe JEV3705(-) (sequences and binding positions
are illustrated in Figure 2B). The assay was performed on
an ABI 7000 Sequence Detector using TaqMan One-Step
RT-PCR master mix to analyze the emitted fluorescence
during amplification (Applied Biosystems). A linear equa-
tion of known amounts of RNA to CT value was
determined.
The intracellular plus- or minus-strand RNAs in JEV-
infected cells were determined by using strand specific
primers during RT step as described above. Cytoplasmic
RNAs were extracted at the indicated time points post-
infection. RNA from each time point was diluted to a
concentration of 100 ng/μla n d1 0n g / μl, respectively,
and subjected to real-time RT-PCR together with the
known amount of in vitro transcripts. The amount of
intracellular genome or antigenome per cell was deter-
mined by dividing the copy number by the numbers of
cells counted at each time point postinfection.
RNA transfection
For run-off transcription, Sal I-linearized pUC18/
JEV10450-10976 or Xba I-linearized pUC18/JEV(-)
10976-10454 were used for making plus- or minus-
strand form of the sfRNA, respectively. Before RNA
transfection, cells in 6-well plates at 50 to 80% conflu-
ence (approximately 2 × 10
6 cells) were infected with
JEV RP9 at an MOI of 0.01 by incubating cells with
inoculum at 37°C for 1 h, refeeding with 2 ml of growth
medium containing 5% FBS, and incubating at 37°C for
27 h. For transfection, each dish of cells was rinsed
three times with RPMI and treated for 10 min at 0°C
with 200 μl of Opti-MEM medium (Gibco-BRL) con-
taining 10 μl of lipofectin (Invitrogen) and 1 μgo fR N A
transcripts. Cells were rinsed with 2 ml of RPMI med-
ium three times and incubated at 37°C with 2 ml of
medium containing 5% FBS until cytoplasmic RNA
extraction was done at the indicated time points.
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JEV minicon (kindly provided by Dr. Yi-Ling Lin) con-
tains a Renilla luciferase (Rluc) fused in-frame to the
JEV coding regions as a single ORF in the following
order; the core (nt 96-158), Rluc (933 nts), E (nt 2388-
2477), NS1 (nt 2478-2693), and NS5 (nt 10203-10391),
and this ORF unit was flanked by the authentic JEV 5’-
and 3’-UTRs (Figure 4A). The Rluc-reporter plasmid
was transcribed using a Megascript SP6 Transcription
kit (Ambion) according to the manufacturer’si n s t r u c -
tions, in the presence or absence of
m7GpppA nucleo-
tide (New England Biolabs). Luciferase assays were
performed using extracts from transfected cells and also
from the in vitro translation assay. For in vivo transla-
tion in cultured cells, 1 μg of transcribed minicon RNA,
together with 1 μg of plus- or minus-strand of sfRNA
were transfected into BHK-21 cells using Lipofectamin
2000 (Invitrogen). Renilla luciferase activity was mea-
sured at 8 hour posttransfection. For in vitro translation,
50 ng of RNAs were translated in nuclease-treated rab-
bit reticulocyte lysate (Promega) in the presence of 40
units of RNasin Ribonuclease Inhibitor (Promega), 20
μM of each amino acid, and either plus-strand, minus-
strand of sfRNA, or a 445-nt control RNA composed of
JEV sequences (nt 2401-2689) plus 156 nts derived from
vector sequences. The reactions were incubated at 30°C
for 30 min and 2.5 μl of reaction sample was measured
with 20/20
n Single-Tube Luminometer (Promega).
Statistical analysis
For statistical analysis, one-way ANOVA Dunnet’sm u l -
tiple comparisons test was used to compare the control
group against others (GraphPad Software, San Diego,
CA, USA).
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